Print
|
Close
A Phase II Trial of Reduced Intensity Fludarabine and Total Body Irradiation-Based Conditioning Prior to Haplo-Identical Transplantation for Patients With Hematologic Malignancies
Active:
Yes
Cancer Type:
Hematopoietic Malignancies
NCT ID:
NCT05417971
Trial Phases:
Phase II
Protocol IDs:
NSH 1347 (primary)
Eligibility:
18 Years and older (Adult, Older Adult ), Male and Female
Study Type:
Study Sponsor:
Northside Hospital, Inc
NCI Full Details:
https://clinicaltrials.gov/study/NCT05417971
Treatment Sites in Georgia
Northside Hospital Cancer Institute - Bone Marrow Transplant (BMT)
1000 Johnson Ferry Road NE
Atlanta, GA 30342
404-851-8523
**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts...
Click here to learn more about clinical trials
.